Phoenix Rising:  Ritixumab Shows Early Potential to Change Conceptualization of CFS

  Unraveling the Mystery of CFS:  Stanford Researchers Focus on Genes Immune System

  Research Efforts Fueled by "Worst Kind of Suffering"

Washington Post: With His Son Terribly Ill, Top Scientist Takes On "Last Major Disease We Don't Know Anything About"

 Chronic Fatigue Syndrome
(CFS) News
Columbia University:  Distinct Immune Profile Explains Disabling Symptoms of Early-Phase SEID, Immunoregulating Drugs In Works

Lipkin/Columbia Univ.:   "Unequivocal Evidence"

Wall Street Journal:  Immune Profiles in CFS Distinct, Disabling

Maupin:  Why the IOM Committee Made the Right Move

New York Times:  Findings May
Lead to Diagnostic/Research Tool


Author Tompkins:  "Ticks the Boxes"

Washington Post:   CFS Definitions Muddy The Water, As New Research Offers Hope

Face the Nation:  'Unbroken' Author Speaks of Book, Personal Struggle

CFS Linked to Unique MRI Abnormalities and Inflammation:  Stanford

Protest at Bethesda

Miriam Tucker Details CFS Research:   Wrong Name, Real Illness

Straus/Fukuda Letters:  Were HHS Efforts in 1994 to Redefine CFS An Effort to Make a Distinct Ilness "Evaporate"?  

US District Court:   NIH Violated Federal Laws in Withholding CFS Documents

ABC News:   Enterovirus Link To Be Explored 

Massey University Study:   CFS Carries a High Personal Cost

Llewellyn King:  Waiting for an Awakening?

Author Hillenbrand Speaks To 'Elle' Magazine About Life with CFS

 Unique Antibodies Found in Subset of CFS Patients:   Ohio State

   Discover Magazine:   Could B Cells Be the Cause of CFS?  

 Harvard Student Speaks Out About Severity Of "Devastating Disease"

Tuller:   Federal Funding for Immunological Breakthroughs Lags

A Disease Like No Other:   The Personal Costs of CFS

   Video Palo/Alto Online:   The Nation's Invisible Illness, Stories of CFS

  Ritixumab --An Autoimmune Drug--- Show Early Promise in Small Controlled Trial

Today, the IOM delivered news that the defining features of the illness must be present in the definition and name, a move that was heralded as a positive step by many CFS clinicians and patients.  


 Short Takes 

July 2015

Will Small Ritixumab Trial' Success Encourage Early Research To Get Closer Look?

Recently, many scientists have stated that the breadth and continual presence of studies confirming immunological problems in CFS should put the matter of whether CFS is an illness or a mere complaint of fatigue to rest.  Despite the empirical evidence, many clincians and scientists seem either unaware of the growing body of evidence or dismissive.   

The evidence of immunlogical issues with CFS keeps piling up.   Following Ian Lipkins study last month is a new trial of Ritixumab, a drug often used in autoimmune disorders.    In a blinded trial of 18 people with CFS, it reversed the illness for 2/3 of patients in a few months, typical of the effects Ritixumab has seen with other authoimmune illnesses, such as rheumatoid arthritis.   Within a year, those who received benefit slowly relapsed.   Though the drug did not achieve lasting remission, the trial's purpose (and the use of Ritixumab) is more of a proof or concept, rather than a search for a treatment.   The study is meant to illustrate that mechanisms behind CFS, it appears, are very similar to other autoimmune illnesses and tied strongly to the immune system.  

A Friend of the CFS Community, Dr. Les Simpson, Passes

The CFS community lost one of its champions recently when Dr. Les Simpson passed.    Dr. Simpson, a pathologist from New Zealand, worked on circulatory abnormalities in ME and CFS long before such research became commonplace.  Having spoken and interacted with Dr. Simpson, he was a class act and generous man in every way.    Les Simpson will be missed, but never forgotten.  

Is the HHS Sticking with CFS and Fukuda?

After the unexpected surprise that the IOM Report on CFS was thorough and true to the science, attention shifted to the HHS response to the report.    The response from the HHS --  or non-response --appears to be a disappointment so far.   Though the HHS claims it is waiting for the release of the P2P report early this summer, one can't help but wonder if some of the higher ups at the health department simply see the IOM as a report as a report best ignored.    Opportunity lost once again. 

Right idea?   Wrong guy?  

The World Health Organization recently made a splash with a program to ensure names, terminology, and public policy for diseases are sensitive to the populations they serve.

WHO Guidelines for protecting populations from harmful terms

  The concept behind the program is a good idea, of course, but I'll just be blunt and say I have a problem with the bureaucrat chosen by the World Health Organization to lead the effort, Keiji Fukuda.   While at the CDC, Keiji Fukuda had every opportunity to put principles of science  into play when it become clear Stephen Straus intended both the term "fatigue syndrome" and the "Fukuda definition" to do damage to a serious and distinct disease.  These two goals were not a proper use of authority then, and even worse, they were anti-science.   The damage done and the HHS and Fukuda wasn't benign, and that damage affects people with CFS/SEID/ME every single day in numerous ways - -clinically, socially, financially, and medically.  

Personal attributions and intentions surface behind CFS term and definition

  I can't help but feel the person the WHO chose to lead a program on "sensitive naming of illnesses" is a man who is trying to rewrite the history of the decades of damage done to millions of sufferers of one of the world's harshest diseases.   And, for this observer, such efforts are not effective, to say the least.

 Series >   Research   Personal Stories
Full list of Series on the Archives Page

Advocacy Ruts 
1 2 3 4 5

A Disease Like No Other
1 2 3 4 5

Shaky Foundation
1 2 3 4 5

CFS at the NIH
1 2 3 4 5

Interview with Dr. Vivian Pinn, Director of ORWH at the NIH

International Consensus Case Definition To Be Published

OP/ED:    Common Language Spoken At CDC's Stakeholder's Meeting In Atlanta


CFS:  Author Finds Beauty and Meaning in the Life of a Snail

Author Escapes Illness with Stirring Seabiscuit

Hillenbrand Discusses  CFS

Skloot's essays, poems make waves

Would you like to use an article here for you support group, forum, or website?   Just copy and paste!

Do you have a story, idea, or suggestion about Chronic Fatigue Syndrome (CFS).  Send it in!